APA (7th ed.) Citation

Longoni, M., Scilipoti, P., De Angelis, M., Re, C., Bertini, A., Avesani, G., . . . Moschini, M. (2023). A0285 - Validation of the novel risk-class for non-muscle invasive bladder cancer: Comparison of oncological outcomes between very-high risk and high risk patients. European Urology, 83, S413. https://doi.org/10.1016/S0302-2838(23)00334-2

Chicago Style (17th ed.) Citation

Longoni, M., et al. "A0285 - Validation of the Novel Risk-class for Non-muscle Invasive Bladder Cancer: Comparison of Oncological Outcomes Between Very-high Risk and High Risk Patients." European Urology 83 (2023): S413. https://doi.org/10.1016/S0302-2838(23)00334-2.

MLA (9th ed.) Citation

Longoni, M., et al. "A0285 - Validation of the Novel Risk-class for Non-muscle Invasive Bladder Cancer: Comparison of Oncological Outcomes Between Very-high Risk and High Risk Patients." European Urology, vol. 83, 2023, p. S413, https://doi.org/10.1016/S0302-2838(23)00334-2.